Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
fda
5
×
life sciences
national blog main
boston
boston top stories
clinical trials
deals
investing
san diego blog main
san francisco blog main
startups
drug delivery
indiana blog main
ipo
medical device
new york blog main
raleigh-durham blog main
san diego top stories
seattle blog main
vc
venture capital
480 biomedical
accent therapeutics
aducanumab
akouos
alzheimer's disease
amblyotech
arrowmark partners
arsenal medical
asklepios biopharmaceutical
astellas pharmaceuticals
beta bionics
bigfoot biomedical
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
bob langer
What
developing
5
×
ipo
medicines
million
therapeutics
company
drug
fda
new
raised
tests
treat
activity
affects
americans
approvals
approved
beta
bio
biogen
bionics
biotech
blood
brings
clamped
closed
covid
date
debut
delays
device
diabetes
disorders
driven
dyne
dyne’s
economic
fast
frequency
genetic
Language
unset
Current search:
fda
×
biotech
×
developing
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests